Literature DB >> 25472542

Prolactin in inflammatory response.

Ana Laura Pereira Suarez1, Gonzalo López-Rincón, Priscila A Martínez Neri, Ciro Estrada-Chávez.   

Abstract

Prolactin (PRL) is a peptide hormone produced by the pituitary gland and diverse extrapituitary sites, which triggers activation of various signaling pathways after binding to its receptor (PRLr) resulting in the activation of specific genes associated with the pleiotropic activities of PLR. To date, various PRLr isoforms have been described, generated by post-transcriptional or post-translational processes. PRL has been associated with the modulation of a variety of actions in the immune response and inflammatory processes in several physiologic and pathologic conditions. However, PRL can have opposite effects, which might be regulated by interaction with the various isoforms of PRLR and PRL variants, as well as the cellular and molecular microenvironment influence.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25472542     DOI: 10.1007/978-3-319-12114-7_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  14 in total

1.  Prolactin is Not Associated with Disability and Clinical Forms in Patients with Multiple Sclerosis.

Authors:  Wildéa Lice de Carvalho Jennings Pereira; Tamires Flauzino; Daniela Frizon Alfieri; Sayonara Rangel Oliveira; Ana Paula Kallaur; Andrea Name Colado Simão; Marcell Alysson Batisti Lozovoy; Damacio Ramón Kaimen-Maciel; Michael Maes; Edna Maria Vissoci Reiche
Journal:  Neuromolecular Med       Date:  2019-08-31       Impact factor: 3.843

Review 2.  Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa.

Authors:  Robert Dantzer
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

3.  Prolactin has a pathogenic role in systemic lupus erythematosus.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Honorio Torres-Aguilar; Carmen Navarro; Monica Vazquez Del Mercado; Luis R Espinoza
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 4.  The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Authors:  Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

5.  Paeoniflorin Ameliorates Hyperprolactinemia-Induced Inhibition of Osteoblastogenesis by Suppressing the NF-κB Signaling Pathway.

Authors:  Xiaohong Sun; Keda Zhu; Chengcheng Feng; Jie Zhu; Shuangshuang Chen; Wenkai Tang; Zhifang Wang; Long Xiao; Hong Li; Dechun Geng; Zhirong Wang
Journal:  Int J Endocrinol       Date:  2022-04-15       Impact factor: 2.803

6.  Circulating levels of hormones, lipids, and immune mediators in post-traumatic stress disorder - a 3-month follow-up study.

Authors:  Mladen Jergović; Krešo Bendelja; Ana Savić Mlakar; Valerija Vojvoda; Neda Aberle; Tanja Jovanovic; Sabina Rabatić; Ante Sabioncello; Anđelko Vidović
Journal:  Front Psychiatry       Date:  2015-04-14       Impact factor: 4.157

7.  Prolactin and Estradiol are Epigenetic Modulators in Bovine Mammary Epithelial Cells during Staphylococcus aureus Infection.

Authors:  María Guadalupe Salgado-Lora; Ivan Medina-Estrada; Joel Edmundo López-Meza; Alejandra Ochoa-Zarzosa
Journal:  Pathogens       Date:  2020-06-28

Review 8.  TRP Channels as Potential Targets for Sex-Related Differences in Migraine Pain.

Authors:  Maite Artero-Morales; Sara González-Rodríguez; Antonio Ferrer-Montiel
Journal:  Front Mol Biosci       Date:  2018-08-14

9.  In vitro decidualisation of human endometrial stromal cells is enhanced by seminal fluid extracellular vesicles.

Authors:  Helena Rodriguez-Caro; Rebecca Dragovic; Mengni Shen; Eszter Dombi; Ginny Mounce; Kate Field; Jamie Meadows; Karen Turner; Daniel Lunn; Tim Child; Jennifer Helen Southcombe; Ingrid Granne
Journal:  J Extracell Vesicles       Date:  2019-01-29

Review 10.  Prolactin and Autoimmunity.

Authors:  Vânia Vieira Borba; Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.